Advancements in Cervical Cancer Treatment Show Promise

A new study presented at the European Society for Medical Oncology conference has revealed that using a short course of induction chemotherapy prior to standard chemoradiation treatment can reduce the risk of death from cervical cancer by 35%. The trial involved 500 patients with cervical cancer, and after five years, 80% of those who received the new treatment were alive and 73% had not experienced a recurrence or spread of the cancer. The findings are being hailed as the most significant breakthrough in treating cervical cancer in the past 20 years.